Scarica l'app Stockscreener
33.92
1.22%
0.41
Precedente Chiudi:
$33.51
Aprire:
$33.5
Volume 24 ore:
45,916
Relative Volume:
0.60
Capitalizzazione di mercato:
$1.54B
Reddito:
Utile/perdita netta:
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
1 W Prestazione:
+11.25%
1M Prestazione:
+29.47%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$29.93
$35.34
Portata 52W:
$21.00
$37.27
Korsana Biosciences, Inc. Common Stock Stock (KRSA) Company Profile
Nome
Korsana Biosciences, Inc. Common Stock
Settore
Industria
Telefono
-
Indirizzo
-
Compare KRSA vs VRTX, MRNA, REGN, ARGX, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KRSA
Korsana Biosciences, Inc. Common Stock
|
33.92 | 1.54B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
510.08 | 129.29B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
225.00 | 89.83B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
746.54 | 76.86B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
825.03 | 51.88B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.76 | 40.67B | 742.00K | -1.37B | -1.07B | -7.0731 |
Korsana Biosciences, Inc. Common Stock Stock (KRSA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-10-05 | Iniziato | Wedbush | Outperform |
| 2026-09-28 | Iniziato | Guggenheim | Buy |
| 2026-09-14 | Iniziato | Stifel | Buy |
| 2026-09-14 | Iniziato | TD Cowen | Buy |
| 2026-09-11 | Iniziato | UBS | Buy |
| 2021-10-20 | Iniziato | Truist | Buy |
| 2021-09-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-03 | Iniziato | Credit Suisse | Neutral |
Mostra tutto
Korsana Biosciences, Inc. Common Stock Borsa (KRSA) Ultime notizie
A passive stake above 5% in Korsana Biosciences (KRSA) is reported by FMR LLC in an amendment. - Stock Titan
Korsana Biosciences (NASDAQ: KRSA) director to sell 100 more shares after 2,139 sold recently - Stock Titan
After two September sales, a Korsana Biosciences (KRSA) director proposes selling 4,903 more shares. - Stock Titan
General Atlantic’s stake in Korsana (CYCN) comes with a strict ownership cap - Stock Titan
Korsana Biosciences (CYCN) director proposes $74.8K stock sale - Stock Titan
A fund reports a 6.1% passive stake in Korsana Biosciences (CYCN), with the investor's identity detailed in the filing. - Stock Titan
Nearly 10% of Korsana Biosciences (CYCN) is tied to one investor group, but its ownership is capped below that line. - Stock Titan
Diluted net income available to common stockholders of Korsana Biosciences, Inc. – NASDAQ:KRSA - TradingView
Korsana Biosciences, Inc. Statistics – NASDAQ:KRSA - TradingView
Investor gains significant stake and board power at Korsana Biosciences (CYCN) - Stock Titan
Korsana Biosciences, Inc. (KRSA) Company Information - Simply Wall Street
Why a 9.99% cap now limits a key Korsana (CYCN) holder - Stock Titan
CFO option stakes detailed at Korsana Biosciences (CYCN) after merger - Stock Titan
Merger gives Korsana Biosciences (CYCN) CMO options expiring in 2036 - Stock Titan
Korsana Biosciences (CYCN) director holds merger-issued option - Stock Titan
New Korsana Biosciences (CYCN) director reports 28,805-share option - Stock Titan
Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million - The Manila Times
CYCN Stock Explodes 313% on April 1 After Cyclerion-Korsana Merger Deal for Alzheimer's Pipeline - International Business Times Australia
Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement - Business Wire
Why is Biotech Stock Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) Gaining? - Investorideas.com
Cyclerion Therapeutics and Korsana Biosciences To Merge - citybiz
Cyclerion Therapeutics and Korsana Biosciences to merge - The Pharma Letter
CYCN Merges with Korsana Biosciences for Strategic Growth - GuruFocus
Korsana Biosciences, Inc. Common Stock Azioni (KRSA) Dati Finanziari
Non sono disponibili dati finanziari per Korsana Biosciences, Inc. Common Stock (KRSA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Korsana Biosciences, Inc. Common Stock Azioni (KRSA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ERROL B DE SOUZA | Director |
Sep 22 '26 |
Proposed Sale |
34.99 |
100 |
3,499 |
0 |
| ERROL B DE SOUZA | Director |
Sep 18 '26 |
Proposed Sale |
34.99 |
2,139 |
74,844 |
0 |
| CHICKO RHONDA M. | Chief Financial Officer |
Aug 14 '26 |
Option Exercise |
2.35 |
25,000 |
58,875 |
25,018 |
| Graul Regina Margaret | See Remarks |
Aug 14 '26 |
Option Exercise |
3.30 |
55,849 |
184,302 |
156,152 |
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):